Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
inflammation
MedTech
Invizius completes first-in-human ‘angry blood’ dialysis study
Invizius' H-Guard priming solution coats the inside of a dialysis machine to cloak the hardware from the blood's heightened immune system response.
Conor Hale
Jun 13, 2024 12:06pm
Takeda gets crafty with molecular glue deal worth $1.2B biobucks
May 23, 2024 5:30am
J&J hooks Proteologix for at least $850M in cash
May 16, 2024 10:12am
Blackstone unsheathes Uniquity Bio with $300M
May 15, 2024 11:00am
Sanofi CSO Frank Nestle is leaving
May 8, 2024 10:00am
Incyte, fresh off gaining MorphoSys drug, buys Escient for $750M
Apr 23, 2024 10:43am